BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10620759)

  • 1. Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates.
    Mercille S; Johnson M; Lanthier S; Kamen AA; Massie B
    Biotechnol Bioeng; 2000 Feb; 67(4):435-50. PubMed ID: 10620759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of redox potential in hybridoma cultures: effects on MAb production, metabolism, and apoptosis.
    Meneses-Acosta A; Gómez A; Ramírez OT
    J Ind Microbiol Biotechnol; 2012 Aug; 39(8):1189-98. PubMed ID: 22526329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody production in semi-continuous serum- and protein-free culture. Effect of glutamine concentration and culture conditions on cell growth and antibody secretion.
    Schneider YJ; Lavoix A
    J Immunol Methods; 1990 May; 129(2):251-68. PubMed ID: 2351840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On-line monitoring of oxygen uptake rate and its application in hybridoma culture].
    Feng Q; Mi L; Li L; Wang XH; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):593-7. PubMed ID: 15969090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fibrous-bed bioreactor for continuous production of monoclonal antibody by hybridoma.
    Yang ST; Luo J; Chen C
    Adv Biochem Eng Biotechnol; 2004; 87():61-96. PubMed ID: 15217104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity.
    Maranga L; Cunha A; Clemente J; Cruz P; Carrondo MJ
    J Biotechnol; 2004 Jan; 107(1):55-64. PubMed ID: 14687971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels.
    Maranga L; Goochee CF
    Biotechnol Bioeng; 2006 May; 94(1):139-50. PubMed ID: 16523524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
    Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
    Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable hybridoma cultivation in a pilot-scale acoustic perfusion system: long-term process performance and effect of recirculation rate.
    Dalm MC; Jansen M; Keijzer TM; van Grunsven WM; Oudshoorn A; Tramper J; Martens DE
    Biotechnol Bioeng; 2005 Sep; 91(7):894-900. PubMed ID: 15959892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies of the culture of mouse hybridomas in an agitated bioreactor with and without continuous sparging.
    Oh SK; Nienow AW; al-Rubeai M; Emery AN
    J Biotechnol; 1992 Feb; 22(3):245-70. PubMed ID: 1367982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NS0 cell damage by high gas velocity sparging in protein-free and cholesterol-free cultures.
    Zhu Y; Cuenca JV; Zhou W; Varma A
    Biotechnol Bioeng; 2008 Nov; 101(4):751-60. PubMed ID: 18814288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic simulation of a centrifugal bioreactor for high population density hybridoma culture.
    Detzel CJ; Mason DJ; Davis WC; van Wie BJ
    Biotechnol Prog; 2009; 25(6):1650-9. PubMed ID: 19806634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-line control of an immobilized hybridoma culture with multi-channel flow injection analysis.
    van der Pol JJ; Joksch B; Gätgens J; Biselli M; de Gooijer CD; Tramper J; Wandrey C
    J Biotechnol; 1995 Dec; 43(3):229-42. PubMed ID: 8590649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.